Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

515
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
515
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

7.0K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
7.0K
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

1.6K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.6K
Methods of Documentation V: CBE01:23

Methods of Documentation V: CBE

1.5K
Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
1.5K
Decision Making: P-value Method01:09

Decision Making: P-value Method

7.1K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can...
7.1K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

58
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
58

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Economic burden of typhoid fever by antimicrobial resistance in India: a modelling study 2023.

The Lancet regional health. Southeast Asia·2026
Same author

Ancestral Wuhan SARS-CoV-2 anti-spike CD4<sup>+</sup> T cells predict protection from symptomatic omicron breakthrough infection.

Vaccine·2026
Same author

Health economics and vaccine financing in the eastern Mediterranean region: A needs assessment.

Vaccine·2025
Same author

Bridging the implementation gap in non-communicable diseases.

Nature medicine·2025
Same author

Estimated global and regional economic burden of genital herpes simplex virus infection among 15-49 year-olds in 2016.

BMC global and public health·2024
Same author

Mapping gaps and exploring impairment and disability prevalence in South Asian (SAARC) countries: a scoping review.

Disability and rehabilitation. Assistive technology·2024
Same journal

Diplomatic roles of regional coordinators for WHO Member States.

Bulletin of the World Health Organization·2026
Same journal

Evaluation of an application for investments in cataract surgery, Ethiopia.

Bulletin of the World Health Organization·2026
Same journal

An umbrella protocol for the clinical evaluation of diagnostics in infectious disease.

Bulletin of the World Health Organization·2026
Same journal

Fundamental changes in regulation to improve access to biosimilars.

Bulletin of the World Health Organization·2026
Same journal

A public-private partnership for facility-based tuberculosis screening using chest radiographs, Viet Nam.

Bulletin of the World Health Organization·2026
Same journal

Ebola at a critical juncture: preparedness must outpace transmission.

Bulletin of the World Health Organization·2026
See all related articles

Related Experiment Video

Updated: Mar 9, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.0K

Cost-effectiveness thresholds: pros and cons.

Melanie Y Bertram1, Jeremy A Lauer1, Kees De Joncheere1

  • 1World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland .

Bulletin of the World Health Organization
|December 21, 2016
PubMed
Summary
This summary is machine-generated.

Cost-effectiveness analysis helps compare health policies. GDP-based thresholds lack specificity, potentially leading to poor resource allocation; context-specific decision-making is crucial for effective healthcare spending.

More Related Videos

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.5K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.6K

Related Experiment Videos

Last Updated: Mar 9, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.0K
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.5K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.6K

Area of Science:

  • Health Economics
  • Health Policy Analysis
  • Decision Science

Background:

  • Cost-effectiveness analysis (CEA) is vital for evaluating health interventions.
  • Cost-effectiveness ratios (CERs) quantify health gains per resource unit.
  • Established thresholds, like those from the World Health Organization based on GDP, guide funding decisions.

Purpose of the Study:

  • To evaluate the utility and limitations of GDP-based cost-effectiveness thresholds.
  • To highlight the need for country-specific approaches in healthcare resource allocation.
  • To advocate for a more comprehensive decision-making framework beyond single threshold values.

Main Methods:

  • Review of cost-effectiveness analysis principles and threshold application.
  • Analysis of the limitations of generalized GDP-based thresholds in diverse country contexts.
  • Examination of factors influencing healthcare resource allocation decisions.

Main Results:

  • GDP-based thresholds lack country specificity, increasing the risk of suboptimal resource allocation.
  • Uncertainty in modelled cost-effectiveness ratios further complicates decision-making.
  • Sole reliance on cost-effectiveness thresholds can lead to inefficient healthcare spending.

Conclusions:

  • Healthcare resource allocation decisions should integrate cost-effectiveness information with other factors like budget impact and feasibility.
  • Countries should develop transparent, consistent, and fair decision-making processes tailored to their specific context.
  • Stakeholder involvement, legislative support, and context-specific thresholds are essential for effective health policy.